DOCSLIB.ORG

Green References01 2018.Pdf

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Green References01 2018.Pdf Toyota Boshoku Controled Substances List Updated： 2018/3/7 ※If you need to know exemption from banning of the use, please check "List of Exemption" sheet Japanese Environment regulation Japanese Safety regulation method of PRTR method of method of Poisonous and （specially 100 kind of VOC Deleterious TB Controled TB Banned PRTR PRTR Industrial Safety Ordinance on Prevention CAS№ Substance Name substances which Ordinance on Substances Substances Substances designated （Class （Class and Health Act. of Dangers due to Heavy New addition need to be notified Prevention of Management Substances subject Specified Chemical Carcinogen note for Class 1） 1） 2） by Japanese Organic Solvent Law. metals [Year/Month] to "GHS Substances. Japanese Environment Poisoning. Poisonous Japanese PRTR Japanese PRTR labeling"and"SDS Specified Chemical PRTR law Ministry Organic solvent Substances/Dele law law reception" Substances [specified chemical [Class 1] [Class 2] terious substances of Substances Category A ] specially 50-00-0 Formaldehyde ○ - 411 411 - 99 548 designated for - - ○ - Class 2 2,4,6(1H,3H,5H)-Pyrimidinetrione, 5-ethyl-5- 50-06-6 ○ - - - - - - - - - - ○ - phenyl- Azirino[2',3':3,4]pyrrolo[1,2-a]indole-4,7-dione, 6- amino-8-[[(aminocarbonyl)oxy]methyl]- 50-07-7 ○ - - - - - - - - - - ○ - 1,1a,2,8,8a,8b-hexahydro-8a-methoxy-5-methyl-, [1aS-(1aa,8b,8aa,8ba)]- 50-18-0 Cyclophosphamide ○ - - - - - - - - - - ○ - 50-28-2 estradiol ○ - - - - - - - - - - - - Benzene, 1,1'-(2,2,2-trichloroethylidene)bis[4- 50-29-3 ○ ○ - - - - 388 - - - - - - chloro- 50-32-8 Benzo[a]pyrene ○ ○ - - - - 534 - - - - ○ - 50-33-9 3,5-Pyrazolidinedione, 4-butyl-1,2-diphenyl- ○ - - - - - - - - - - - - 50-41-9 Clomifen dihydrogen citrate ○ - - - - - - - - - ○ - - 50-44-2 mercaptopurine ○ - - - - - - - - - - - - Yohimban-16-carboxylic acid, 11,17-dimethoxy- 50-55-5 18-[(3,4,5-trimethoxybenzoyl)oxy]-, methyl ester, ○ - - - - - - - - - - - - (3b,16b,17a,18b,20a)- 50-76-0 Dactinomycin ○ - - - - - - - - - - - - 50-78-2 Benzoic acid, 2-(acetyloxy)- ○ - - - - - 12 - - - - - - 51-02-5 Pronetalol hydrochloride ○ - - - - - - - - - - - - 1,3-Benzodioxole, 5-[[2-(2- 51-03-6 ○ - - - - - - - - - - - - butoxyethoxy)ethoxy]methyl]-6-propyl- 51-18-3 tretamine ○ - - - - - - - - - - - - 51-21-8 2,4(1H,3H)-Pyrimidinedione, 5-fluoro- ○ - - - - - - - - - - - - 51-28-5 Phenol, 2,4-dinitro- ○ - - 201 - - - - - 劇物 - - - 4(1H)-Pyrimidinone, 2,3-dihydro-6-propyl-2- 51-52-5 ○ - - - 44 - - - - - - ○ - thioxo- 51-75-2 Ethanamine, 2-chloro-N-(2-chloroethyl)-N-methyl- ○ - - - - - - - - - - ○ - 51-79-6 Carbamic acid, ethyl ester ○ - - - 8 - 60 - - - - ○ - Pregn-4-ene-21-carboxylic acid, 7-(acetylthio)-17- 52-01-7 ○ - - - - - - - - - - - - hydroxy-3-oxo-, g-lactone, (7a,17a)- 52-24-4 thiotepa ○ - - - - - - - - - - ○ - 52-46-0 Apholate ○ - - - - - - - - - - - - 52-51-7 1,3-Propanediol, 2-bromo-2-nitro- ○ - - - - - - - - - - - - 52-68-6 trichlorfon ○ - - 225 - - 292の2 - - 劇物 - - - Phosphorothioic acid, O-[4- 52-85-7 [(dimethylamino)sulfonyl]phenyl] O,O-dimethyl ○ - - - - - - - - - - - - ester Pregna-1,4-diene-3,11,20-trione, 17,21- 53-03-2 ○ - - - - - - - - - - - - dihydroxy- 53-16-7 Estra-1,3,5(10)-trien-17-one, 3-hydroxy- ○ - - - - - - - - - - - - 53-19-0 mitotane ○ - - - - - - - - - - - - 53-70-3 Dibenz[a,h]anthracene ○ ○ - - - - - - - - - ○ - 53-96-3 Acetamide, N-9H-fluoren-2-yl- ○ - - - - - - - - - - - - 54-05-7 Chloroquine ○ - - - - - - - - - - - - 54-11-5 Pyridine, 3-(1-methyl-2-pyrrolidinyl)-, (S)- ○ - - - - - 413 - - 毒物 - - - Benzoic acid, 5-(aminosulfonyl)-4-chloro-2-[(2- 54-31-9 ○ - - - - - - - - - - - - furanylmethyl)amino]- Sodium ethanide[2-(sulfide-kappaS)benzoato- 54-64-8 ○ ○ - 237 - - 33 - - 劇物 ○ - Jan-14 kappaO]mercurate(1-) 54-85-3 4-Pyridinecarboxylic acid, hydrazide ○ - - - - - - - - - - - - 55-18-5 Ethanamine, N-ethyl-N-nitroso- ○ - - - - - - - - - - ○ - 55-21-0 Benzamide ○ - - - - - - - - - - - - 55-38-9 fenthion ○ - - 252 - - 350 - - 劇物 - - - 55-63-0 1,2,3-Propanetriol, trinitrate ○ - - 313 - - 423 - - - - - - 55-86-7 chlormethine hydrochloride ○ - - - - - - - - - - - - 55-98-1 busulfan ○ - - - - - - - - - - ○ - 4(1H)-Pyrimidinone, 2,3-dihydro-6-methyl-2- 56-04-2 ○ - - - - - - - - - - ○ - thioxo- 56-23-5 Methane, tetrachloro- ○ ○ - 149 - - 226 第2類(有機)㊕ - 劇物 - ○ - 4,7-Epoxyisobenzofuran-1,3-dione, hexahydro- 56-25-7 ○ - - - - - - - - - - - - 3a,7a-dimethyl-, (3aa,4b,7b,7aa)- 56-35-9 Distannoxane, hexabutyl- ○ ○ - 239 - - 322 - - 劇物 ○ - - 56-36-0 tributyltin acetate ○ ○ - 239 - - 322 - - 劇物 ○ - - 56-38-2 parathion ○ ○ - - - - 223 - - 特定毒物 - - - 56-53-1 Phenol, 4,4'-(1,2-diethyl-1,2-ethenediyl)bis-, (E)- ○ - - - - - - - - - - ○ - 56-55-3 Benz[a]anthracene ○ ○ - - - - 533 - - - - ○ - 56-72-4 Coumaphos ○ - - - - - 162の2 - - - - - - Acetamide, 2,2-dichloro-N-[2-hydroxy-1- 56-75-7 (hydroxymethyl)-2-(4-nitrophenyl)ethyl]-, [R- ○ - - - 30 - - - - - - ○ - (R*,R*)]- 56-81-5 1,2,3-Propanetriol ○ - - - - - - - - - - - - 56-93-9 Benzyltrimethylammonium chloride ☆ - - - - - - - - - - - Mar-18 57-09-0 1-Hexadecanaminium, N,N,N-trimethyl-, bromide ○ - - - 85 - - - - - - - - 57-12-5 Cyanide ○ ○ - - - - - - - 劇物 ○ - - 57-14-7 Hydrazine, 1,1-dimethyl- ○ ○ - 226 - - 295 第2類(特定)㊕ - 劇物 - ○ - 57-24-9 Strychnidin-10-one ○ - - - - - 328 - - 毒物 - - - 2,4,6(1H,3H,5H)-Pyrimidinetrione, 5-ethyl-5-(1- 57-33-0 ○ - - - - - - - - - - - - methylbutyl)-, monosodium salt 57-39-6 Aziridine, 1,1',1''-phosphinylidynetris[2-methyl- ○ - - - - - - - - - - - - 57-41-0 phenytoin ○ - - - - - - - - - - ○ - a-D-Glucopyranoside, 57-50-1 ○ - - - - - - - - - - - - b-D-fructofuranosyl 57-55-6 Propane-1,2-diol ○ - - - - - - - - - - - Mar-16 57-57-8 2-Oxetanone ○ ○ - - - - 523 第2類(特定)㊕ - - - ○ - 19-Norpregna-1,3,5(10)-trien-20-yne-3,17-diol, 57-63-6 ○ - - - - - - - - - - - - (17a)- 57-74-9 chlordane , pur ○ ○ - - - - 113 - - 劇物 - ○ - 57-83-0 Pregn-4-ene-3,20-dione ○ - - - - - - - - - - ○ - 57-88-5 Cholest-5-en-3-ol (3b)- ○ - - - - - - - - - - - - 57-97-6 Benz[a]anthracene, 7,12-dimethyl- ○ - - - - - - - - - - - - 58-14-0 pyrimethamine ○ - - - - - - - - - - - - 58-36-6 Diphenoxarsin-10-yl oxide ○ ○ - - - - 458 第2類(管理)㊕ - 劇物 - - Jan-14 58-55-9 1H-Purine-2,6-dione, 3,7-dihydro-1,3-dimethyl- ○ - - - - - - - - - - - - Cyclohexane, 1,2,3,4,5,6-hexachloro-, 58-89-9 ○ ○ - - - - 508 - - 劇物 - ○ - (1a,2a,3b,4a,5a,6b)- 58-90-2 Phenol, 2,3,4,6-tetrachloro- ○ - - - - - - - - - - ○ - 2H-1,2,4-Benzothiadiazine-7-sulfonamide, 6- 58-93-5 ○ - - - - - - - - - - - - chloro-3,4-dihydro-, 1,1-dioxide L-Glutamic acid, N-[4-[[(2,4-diamino-6- 59-05-2 ○ - - - - - - - - - - - - pteridinyl)methyl]methylamino]benzoyl]- 59-50-7 Phenol, 4-chloro-3-methyl- ○ - - 129 - - - - - - - - - Hydrazinecarboxamide, 2-[(5-nitro-2- 59-87-0 ○ - - - - - - - - - - - - furanyl)methylene]- 59-89-2 N-nitrosomorpholine ○ - - - - - 425 - - - - ○ - 60-00-4 Glycine, N,N'-1,2-ethanediylbis[N-(carboxymethyl)- ○ - - 60 - - - - - - - - - 60-09-3 Benzenamine, 4-(phenylazo)- ○ ○ - - - - 446 - - - - ○ - 60-11-7 Benzenamine, N,N-dimethyl-4-(phenylazo)- ○ - - - - - 442 第2類(特定)㊕ - - - ○ - 60-24-2 Ethanol, 2-mercapto- ○ - - - - - - - - 劇物 - - Jan-14 60-29-7 Ethane, 1,1'-oxybis- ○ - - - - - 65 - 第2種 - - - - 60-34-4 Hydrazine, methyl- ○ - - - 93 - 587 - - - - - - 60-35-5 Acetamide ○ - - - 1 - 13 - - - - ○ - Phosphorodithioic acid, O,O-dimethyl S-[2- 60-51-5 ○ - - 198 - - - - - 劇物 - - - (methylamino)-2-oxoethyl] ester 60-57-1 dieldrin ○ ○ - - - - 506 - - 劇物 - - - 61-57-4 niridazole ○ - - - - - - - - - - ○ - 61-82-5 1H-1,2,4-Triazol-3-amine ○ - - - 4 - 23 - - - - ○ - 62-38-4 Mercury, (acetato-kO)phenyl- ○ ○ - 237 - - 29 - - 毒物 ○ - - 62-44-2 Acetamide, N-(4-ethoxyphenyl)- ○ - - - - - - - - - - ○ - 62-50-0 Methanesulfonic acid, ethyl ester ○ - - - - - 561 - - - - ○ - 62-53-3 Benzenamine ○ ○ - 18 - - 19 - - 劇物 - ○ - 62-55-5 Ethanethioamide ○ ○ - - 56 - - - - - - ○ - 62-56-6 Thiourea ○ ○ - 245 - - 340 - - - - ○ - 62-73-7 Phosphoric acid, 2,2-dichloroethenyl dimethyl ester ○ ○ - 457 - - 291 第2類(特定)㊕ - 劇物 - ○ - 62-74-8 Acetic acid, fluoro-, sodium salt ○ ○ - - - - 489 - - 毒物 - - - 62-75-9 Methanamine, N-methyl-N-nitroso- ○ ○ - - - - 293 - - - - ○ - 63-25-2 1-Naphthalenol, methylcarbamate ○ ○ - 427 - - 410 - - 劇物 - - - 63-74-1 Benzenesulfonamide, 4-amino- ○ - - - - - - - - - - - - 63-92-3 phenoxybenzamine hydrochloride ○ - - - - - - - - - - ○ - 64-17-5 Ethanol ○ - - - - 53 61 - - - - - - 64-18-6 Formic acid ○ - - - - - 132 - - 劇物 - - - 64-19-7 Acetic acid ○ - - - - - 176 - - - - - Mar-16 64-67-5 Sulfuric acid, diethyl ester ○ ○ - - - - 615 その他 - - - ○ - 2-Naphthacenecarboxamide, 4-(dimethylamino)- 1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a- 64-75-5 ○ - - - - - - - - - - - - pentahydroxy-6-methyl-1,11-dioxo-, monohydrochloride, [4S-(4a,4aa,5aa,6b,12aa)]- 65-85-0 Benzoic acid ○ - - - - - - - - - - - - 66-27-3 Methanesulfonic acid, methyl ester ○ - - - - - 562 - - - - ○ - 66-75-1 uramustine ○ - - - - - - - - - - ○ - 66-81-9 cicloheximide ○ - - - - - - - - 劇物 - - - 2,4-Imidazolidinedione, 1-[[(5-nitro-2- 67-20-9 ○ - - - - - - - - - - - - furanyl)methylene]amino]- 2-Oxazolidinone, 3-[[(5-nitro-2- 67-45-8 ○ - - - - - - - - - - - - furanyl)methylene]amino]- 67-56-1 Methanol ○ - - - - 6 560 - 第2種 劇物 - - - 67-62-9 O-methylhydroxylamine ○ - - - - - - - - - - - - 67-63-0 2-Propanol ○ - - - - 12 494 - 第2種 - - - - 67-64-1 2-Propanone ○ - - - - 14 17 - 第2種 - - - - 67-66-3 Methane, trichloro- ○ ○ - 127 - 77 160 第2類(有機)㊕ - 劇物 - ○ - 67-72-1 Ethane, hexachloro- ○ ○ - - 82 - 505 - - - - ○ - 68-11-1 Acetic acid, mercapto- ○ - - - - - 602 - - - - - - 68-12-2 N,N-dimethylformamide ; dimethyl formamide ○ - - 232 - 44 299 - 第2種
Load more

Recommended publications
  • Report of the Advisory Group to Recommend Priorities for the IARC Monographs During 2020–2024
    IARC Monographs on the Identification of Carcinogenic Hazards to Humans Report of the Advisory Group to Recommend Priorities for the IARC Monographs during 2020–2024 Report of the Advisory Group to Recommend Priorities for the IARC Monographs during 2020–2024 CONTENTS Introduction ................................................................................................................................... 1 Acetaldehyde (CAS No. 75-07-0) ................................................................................................. 3 Acrolein (CAS No. 107-02-8) ....................................................................................................... 4 Acrylamide (CAS No. 79-06-1) .................................................................................................... 5 Acrylonitrile (CAS No. 107-13-1) ................................................................................................ 6 Aflatoxins (CAS No. 1402-68-2) .................................................................................................. 8 Air pollutants and underlying mechanisms for breast cancer ....................................................... 9 Airborne gram-negative bacterial endotoxins ............................................................................. 10 Alachlor (chloroacetanilide herbicide) (CAS No. 15972-60-8) .................................................. 10 Aluminium (CAS No. 7429-90-5) .............................................................................................. 11
    [Show full text]
  • Compositions Comprising Drospirenone Molecularly
    (19) & (11) EP 1 748 756 B1 (12) EUROPEAN PATENT SPECIFICATION (45) Date of publication and mention (51) Int Cl.: of the grant of the patent: A61K 9/00 (2006.01) A61K 9/107 (2006.01) 29.04.2009 Bulletin 2009/18 A61K 9/48 (2006.01) A61K 9/16 (2006.01) A61K 9/20 (2006.01) A61K 9/14 (2006.01) (2006.01) (2006.01) (21) Application number: 05708751.2 A61K 9/70 A61K 31/565 (22) Date of filing: 10.03.2005 (86) International application number: PCT/IB2005/000665 (87) International publication number: WO 2005/087194 (22.09.2005 Gazette 2005/38) (54) COMPOSITIONS COMPRISING DROSPIRENONE MOLECULARLY DISPERSED ZUSAMMENSETZUNGEN AUS DROSPIRENON IN MOLEKULARER DISPERSION DES COMPOSITIONS CONTENANT DROSPIRENONE A DISPERSION MOLECULAIRE (84) Designated Contracting States: (72) Inventors: AT BE BG CH CY CZ DE DK EE ES FI FR GB GR • FUNKE, Adrian HU IE IS IT LI LT LU MC NL PL PT RO SE SI SK TR D-14055 Berlin (DE) Designated Extension States: • WAGNER, Torsten AL BA HR MK YU 13127 Berlin (DE) (30) Priority: 10.03.2004 EP 04075713 (74) Representative: Wagner, Kim 10.03.2004 US 551355 P Plougmann & Vingtoft a/s Sundkrogsgade 9 (43) Date of publication of application: P.O. Box 831 07.02.2007 Bulletin 2007/06 2100 Copenhagen Ø (DK) (60) Divisional application: (56) References cited: 08011577.7 / 1 980 242 EP-A- 1 260 225 EP-A- 1 380 301 WO-A-01/52857 WO-A-20/04022065 (73) Proprietor: Bayer Schering Pharma WO-A-20/04041289 US-A- 5 569 652 Aktiengesellschaft US-A- 5 656 622 US-A- 5 789 442 13353 Berlin (DE) Note: Within nine months of the publication of the mention of the grant of the European patent in the European Patent Bulletin, any person may give notice to the European Patent Office of opposition to that patent, in accordance with the Implementing Regulations.
    [Show full text]
  • A Guide to Export Controls
    Foreign Affairs, Trade and Affaires étrangères, Commerce et Development Canada Développment Canada A Guide To CANADA’S EXPORT CONTROLS December 2012 Introduction The issuance of export permits is administered by the Export Controls Division (TIE) of Foreign Affairs, Trade and Development Canada (DFATD). TIE provides assistance to exporters in determining if export permits are required. It also publishes brochures and Notices to Exporters that are freely available on request and on our website www.exportcontrols.gc.ca. How to contact us: Export Controls Division (TIE) Foreign Affairs, Trade and Development Canada 111 Sussex Drive Ottawa, Ontario K1A 0G2 Telephone: (613) 996-2387 Facsimile: (613) 996-9933 Email: [email protected] For information on how to apply for an export permit and additional information on export controls please refer to our website. To enquire on the status of an export permit application: Recognized EXCOL users can check the status of an export permit application on-line. Non-recognized users can call (613) 996-2387 or email [email protected] and quote your export permit application identification (ref ID) number. Export Controls Division website: www.exportcontrols.gc.ca This Guide, at time of publication, encompasses the list of items enumerated on the Export Control List (ECL) that are controlled for export in accordance with Canadian foreign policy, including Canada’s participation in multilateral export control regimes and bilateral agreements. Unless otherwise specified, the export controls contained in this Guide apply to all destinations except the United States. Canada’s Export Control List can be found at the Department of Justice website at http://canada.justice.gc.ca/.
    [Show full text]
  • California Proposition 65 Toxicity List
    STATE OF CALIFORNIA ENVIRONMENTAL PROTECTION AGENCY OFFICE OF ENVIRONMENTAL HEALTH HAZARD ASSESSMENT SAFE DRINKING WATER AND TOXIC ENFORCEMENT ACT OF 1986 CHEMICALS KNOWN TO THE STATE TO CAUSE CANCER OR REPRODUCTIVE TOXICITY 4-Mar-05 The Safe Drinking Water and Toxic Enforcement Act of 1986 requires that the Governor revise and Chemical Type of Toxicity CAS No. Date Listed A-alpha-C (2-Amino-9H-pyrido[2,3-b]indole) cancer 26148685 1-Jan-90 Acetaldehyde cancer 75070 1-Apr-88 Acetamide cancer 60355 1-Jan-90 Acetazolamide developmental 59665 20-Aug-99 Acetochlor cancer 34256821 1-Jan-89 Acetohydroxamic acid developmental 546883 1-Apr-90 2-Acetylaminofluorene cancer 53963 1-Jul-87 Acifluorfen cancer 62476599 1-Jan-90 Acrylamide cancer 79061 1-Jan-90 Acrylonitrile cancer 107131 1-Jul-87 Actinomycin D cancer 50760 1-Oct-89 Actinomycin D developmental 50760 1-Oct-92 Adriamycin (Doxorubicin hydrochloride) cancer 23214928 1-Jul-87 AF-2;[2-(2-furyl)-3-(5-nitro-2-furyl)]acrylamide cancer 3688537 1-Jul-87 Aflatoxins cancer --- 1-Jan-88 Alachlor cancer 15972608 1-Jan-89 Alcoholic beverages, when associated with alcohol abuse cancer --- 1-Jul-88 Aldrin cancer 309002 1-Jul-88 All-trans retinoic acid developmental 302794 1-Jan-89 Allyl chloride Delisted October 29, 1999 cancer 107051 1-Jan-90 Alprazolam developmental 28981977 1-Jul-90 Altretamine developmental, male 645056 20-Aug-99 Amantadine hydrochloride developmental 665667 27-Feb-01 Amikacin sulfate developmental 39831555 1-Jul-90 2-Aminoanthraquinone cancer 117793 1-Oct-89 p -Aminoazobenzene cancer
    [Show full text]
  • June 2009 MONTHLY MEETING : PLEASE PAY YOUR DUES: WHEN? Monday, June 22, 2009 – the Fourth Monday of in Accordance with the By-Laws, Dues, in the the Month
    Spore-Addct The Newsletter of the Pikes PeakTime Mycological Society 1974 – 2009 Vol. XXXV ISSUE 3 June 2009 MONTHLY MEETING : PLEASE PAY YOUR DUES: WHEN? Monday, June 22, 2009 – The fourth Monday of In accordance with the By-laws, dues, in the the month. amount of $15.00, are due and payable on or before the April monthly meeting. If you still WHAT TIME? 6:30 pm; the meeting will come to order at have not paid, please pay at the June meeting or 7:00 pm. mail the payment to PPMS, PO Box 39, Colorado Springs, CO 80901-0039. Thanks! WHERE? Pikes Peak National Bank, 2401 W. Colorado Ave. (across from Bancroft Park). Enter at the door on Colorado Ave., just west of the bank door. There you will find stairs and an elevator. You may use either. The FORAY REPORT: room is on the second floor near the head of the stairs. May 30th 2009: Ten of us (including 2 newcomers to WEBSITE: http://www.pikespeakmushrooms.com/ PPMS) gathered at the Red Rocks Safeway parking lot at 8:30 a.m. All had either been contacted by e-mail or PROGRAM: personal phone call. All club forays will be scheduled like this. Our eager forayers found only 6 small morels, A NAMA Educational Program: 2 L.B.Ms, and some dubious polypors. We did come “Guide to the Major Genera of Gilled Mushrooms: The across 6 Calypso orchids (unaccompanied by morels). Light Spored Mushrooms I: Pluteaceae, Pleurotaceae, It was a beautiful day on Rampart Range Road. Rain Entolomataceae, Marasmiaceae and Others” and warmer temperatures have brought out city This program covers the best edible and most mushrooms galore.
    [Show full text]
  • Cadmium- Toxfaqs™
    Cadmium- ToxFAQs™ CAS # 7440-43-9 This fact sheet answers the most frequently asked health questions (FAQs) about cadmium. For more information, call the CDC Information Center at 1-800-232-4636. This fact sheet is one in a series of summaries about hazardous substances and their health effects. It is important you understand this information because this substance may harm you. The effects of exposure to any hazardous substance depend on the dose, the duration, how you are exposed, personal traits and habits, and whether other chemicals are present. HIGHLIGHTS: Exposure to cadmium happens mostly in the workplace where cadmium products are made. The general population is exposed from breathing cigarette smoke or eating cadmium contaminated foods. Cadmium damages the kidneys, lungs, and bones. Cadmium has been found in at least 1,014 of the 1,669 National Priorities List (NPL) sites identified by the Environmental Protection Agency (EPA). What is cadmium? How might I be exposed to cadmium? Cadmium is a natural element in the earth’s crust. It is • Eating foods containing cadmium; low levels are usually found as a mineral combined with other elements found in all foods (highest levels are found in leafy such as oxygen (cadmium oxide), chlorine (cadmium vegetables, grains, legumes, and kidney meat). chloride), or sulfur (cadmium sulfate, cadmium sulfide). • Smoking cigarettes or breathing cigarette smoke. All soils and rocks, including coal and mineral fertilizers, • Breathing contaminated workplace air. contain some cadmium. Most cadmium used in the United States is extracted during the production of other metals • Drinking contaminated water. like zinc, lead, and copper.
    [Show full text]
  • COMBINED LIST of Particularly Hazardous Substances
    COMBINED LIST of Particularly Hazardous Substances revised 2/4/2021 IARC list 1 are Carcinogenic to humans list compiled by Hector Acuna, UCSB IARC list Group 2A Probably carcinogenic to humans IARC list Group 2B Possibly carcinogenic to humans If any of the chemicals listed below are used in your research then complete a Standard Operating Procedure (SOP) for the product as described in the Chemical Hygiene Plan. Prop 65 known to cause cancer or reproductive toxicity Material(s) not on the list does not preclude one from completing an SOP. Other extremely toxic chemicals KNOWN Carcinogens from National Toxicology Program (NTP) or other high hazards will require the development of an SOP. Red= added in 2020 or status change Reasonably Anticipated NTP EPA Haz list COMBINED LIST of Particularly Hazardous Substances CAS Source from where the material is listed. 6,9-Methano-2,4,3-benzodioxathiepin, 6,7,8,9,10,10- hexachloro-1,5,5a,6,9,9a-hexahydro-, 3-oxide Acutely Toxic Methanimidamide, N,N-dimethyl-N'-[2-methyl-4-[[(methylamino)carbonyl]oxy]phenyl]- Acutely Toxic 1-(2-Chloroethyl)-3-(4-methylcyclohexyl)-1-nitrosourea (Methyl-CCNU) Prop 65 KNOWN Carcinogens NTP 1-(2-Chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU) IARC list Group 2A Reasonably Anticipated NTP 1-(2-Chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU) (Lomustine) Prop 65 1-(o-Chlorophenyl)thiourea Acutely Toxic 1,1,1,2-Tetrachloroethane IARC list Group 2B 1,1,2,2-Tetrachloroethane Prop 65 IARC list Group 2B 1,1-Dichloro-2,2-bis(p -chloropheny)ethylene (DDE) Prop 65 1,1-Dichloroethane
    [Show full text]
  • In the United States Court of Appeals for the Federal Circuit
    Case: 18-1959 Document: 16 Page: 1 Filed: 08/20/2018 No. 18-1959 In the United States Court of Appeals for the Federal Circuit GENENTECH, INC., APPELLANT v. HOSPIRA, INC., APPELLEE ON APPEAL FROM THE UNITED STATES PATENT AND TRADEMARK OFFICE PATENT TRIAL AND APPEAL BOARD IN NO. IPR2016-01771 BRIEF OF APPELLANT GENENTECH, INC. PAUL B. GAFFNEY ADAM L. PERLMAN THOMAS S. FLETCHER WILLIAMS & CONNOLLY LLP 725 Twelfth Street, N.W. Washington, DC 20005 (202) 434-5000 Case: 18-1959 Document: 16 Page: 2 Filed: 08/20/2018 CERTIFICATE OF INTEREST Pursuant to Federal Circuit Rule 47.4, undersigned counsel for appellant certifies the following: 1. The full name of the party represented by me is Genentech, Inc. 2. The name of the real party in interest represented by me is the same. 3. Genentech, Inc. is a wholly-owned subsidiary of Roche Holdings Inc. Roche Holdings Inc.’s ultimate parent, Roche Holdings Ltd, is a publicly held Swiss corporation traded on the Swiss Stock Exchange. Upon information and belief, more than 10% of Roche Holdings Ltd’s voting shares are held either directly or indirectly by Novartis AG, a publicly held Swiss corporation. 4. The following attorneys appeared for Genentech, Inc. in proceedings below or are expected to appear in this Court and are not already listed on the docket for the current case: Teagan J. Gregory and Christopher A. Suarez of Williams & Connolly LLP, 725 Twelfth Street, N.W., Washington, D.C. 20005. 5. The title and number of any case known to counsel to be pending in this or any other court or agency that will directly affect or be directly affected by this court’s decision in this pending appeal are Genentech, Inc.
    [Show full text]
  • Draft Permit
    Air Individual Permit Major Amendment 14900013-104 Permittee: DENCO II LLC Facility name: DENCO II LLC 227 County Road 22 Morris, MN 56267-4691 Stevens County Operating permit issuance date: May 1, 2019 Expiration date: May 1, 2024 * All Title I Conditions do not expire Major Amendment: [Action Issue Date] Permit characteristics: State; Limits to avoid Part 70/ Limits to avoid NSR; Limits to avoid NSR The emission units, control equipment and emission stacks at the stationary source authorized in this permit amendment are as described in the submittals listed in the Permit Applications Table. This permit amendment supersedes Air Emission Permit No. 14900013-103 and authorizes the Permittee to operate the stationary source at the address listed above unless otherwise noted in the permit. The Permittee must comply with all the conditions of the permit. Any changes or modifications to the stationary source must be performed in compliance with Minn. R. 7007.1150 to 7007.1500. Terms used in the permit are as defined in the state air pollution control rules unless the term is explicitly defined in the permit. Unless otherwise indicated, all the Minnesota rules cited as the origin of the permit terms are incorporated into the SIP under 40 CFR § 52.1220 and as such are enforceable by U.S. Environmental Protection Agency (EPA) Administrator or citizens under the Clean Air Act. Signature: [ ] This document has been electronically signed. for the Minnesota Pollution Control Agency for Steven S. Pak, P.E., Manager Air Quality Permits Section Industrial Division Table of Contents Page 1. Permit applications table ............................................................................................................................................
    [Show full text]
  • Circular of the Bureau of Standards No. 539 Volume 10: Standard X-Ray
    :ationa.u d H.W. BIS <T be Libra.ry, Reisrence book not to 1965 JVPR 1 6 from ibe lib s ary. taken NBS C | RCULAR 539 VOLUME 10 Standard X-ray Diffraction Powder Patterns UNITED STATES DEPARTMENT OF COMMERCE NATIONAL BUREAU OF STANDARDS THE NATIONAL BUREAU OF STANDARDS Functions and Activities The Functions of the National Bureau of Standards are set forth in the Act of Congress, March 3, 1901, as amended by Congress in Public Law 619, 1950. These include the development and maintenance of the national standards of measurement and the provision of means and methods for making measurements consistent with these standards; the determination of physical constants and properties of materials; the development of methods and instruments for testing materials, devices, and structures; advisory services to government agencies on scientific and technical problems; in- vention and development of devices to serve special needs of the Government; and the development of standard practices, codes, and specifications. The work includes basic and applied research, development, engineering, instrumentation, testing, evaluation, calibration services, and various consultation and information services. Research projects are also performed for other government agencies when the work relates to and supplements the basic program of the Bureau or when the Bureau’s unique competence is required. The scope of activities is suggested by the listing of divisions and sections on the inside of the back cover. Publications The results of the Bureau’s work take the form of either actual equipment and devices or pub- lished papers. These papers appear either in the Bureau’s own series of publications or in the journals of professional and scientific societies.
    [Show full text]
  • (12) United States Patent (10) Patent No.: US 8,828,435 B2 Hewitt Et Al
    USOO88284.35B2 (12) United States Patent (10) Patent No.: US 8,828,435 B2 Hewitt et al. (45) Date of Patent: Sep. 9, 2014 (54) BUCCAL DELIVERY SYSTEM 2002/0114833 A1 8/2002 Abu-IZZa et al. 2004/0019026 A1 1/2004 Schwartz ...................... 514,177 2004/0028732 A1 2/2004 Falkenhausen et al. (75) Inventors: Ernest Alan Hewitt, Windsor Downs 2004/0037878 A1 2/2004 Szamosi et al. (AU); Richard James Stenlake, Double 2006, O141027 A1 6, 2006 Cioli Day (AU) FOREIGN PATENT DOCUMENTS (73) Assignee: Lingual Consegna Pty Ltd (AU) EP 215635 3, 1987 (*) Notice: Subject to any disclaimer, the term of this GB 1248.189 9, 1971 patent is extended or adjusted under 35 W. wo: iii. U.S.C. 154(b) by 85 days. WO WO9904758 2, 1999 WO WOO189485 11, 2001 (21) Appl. No.: 13/021,578 WO 2004075877 A1 9, 2004 (22) Filed: Feb. 4, 2011 OTHER PUBLICATIONS (65) Prior Publication Data Velaz I., et al., “Effect of PEG 4000 on the Dissolution Rate of Naproxen”, European Journal of Drug Metabolism & US 2011 FO123619 A1 May 26, 2011 Pharmacokinetics, vol. 23, No. 2, pp. 103-108 (Apr.-Jun. 1998). Runkel, R., et al., "Naproxen Oral Absorption Characteristics'. Related U.S. Application Data Chem. Pharm. Bull. vol. 70, No. 7, pp. 1457-1466 (197p). Ranucci E. et al., “Pharmacokinetic Results on Naproxen Prodrugs (63) Continuation of application No. 1 1/910.902, filed as Based on Poly(ethyleneglycol)s', J Biomater Sci Polymer Edn, vol. application No. PCT/AU2006/000472 on Apr. 7, 2006, 6, No.
    [Show full text]
  • WO 2015/121485 Al 20 August 2015 (20.08.2015) P O P C T
    (12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (10) International Publication Number (43) International Publication Date WO 2015/121485 Al 20 August 2015 (20.08.2015) P O P C T (51) International Patent Classification: (81) Designated States (unless otherwise indicated, for every B01J 23/18 (2006.01) B01J 35/02 (2006.01) kind of national protection available): AE, AG, AL, AM, B01J 23/22 (2006.01) C07C 15/24 (2006.01) AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, B01J 27/198 (2006.01) B01J 37/00 (2006.01) BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, B01J 35/00 (2006.01) DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JP, KE, KG, KN, KP, KR, (21) International Application Number: KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, PCT/EP2015/053270 MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, (22) International Filing Date: PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, 17 February 2015 (17.02.2015) SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW. (25) Filing Language: English (84) Designated States (unless otherwise indicated, for every (26) Publication Language: English kind of regional protection available): ARIPO (BW, GH, (30) Priority Data: GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, 14155332.
    [Show full text]